Filter
1504
Filtered Results: 1504
Text search:
vaccine
trial
Featured
Recommendations
178
New Publications
333
Language
Document type
No document type
662
Studies & Reports
289
Guidelines
257
Manuals
93
Fact sheets
74
Strategic & Response Plan
64
Situation Updates
20
Training Material
17
Resource Platforms
12
Infographics
7
Videos
6
Brochures
2
App
1
Countries / Regions
Global
75
India
43
Sierra Leone
35
Liberia
35
Kenya
34
Nigeria
29
South Africa
28
Ethiopia
24
Western and Central Europe
22
Uganda
21
West and Central Africa
20
Latin America and the Carribbean
19
East and Southern Africa
18
Brazil
18
Africa
17
Guinea
16
Congo, Democratic Republic of
15
Russia
14
Ukraine
13
Ghana
13
Zambia
13
Rwanda
12
Bangladesh
12
Eastern Europe
12
Tanzania
11
Nepal
10
Malawi
10
Mozambique
10
Germany
10
South Sudan
10
Syria
9
Zimbabwe
9
Philippines
9
Cambodia
9
South–East Asia Region
9
Myanmar / Burma
9
Middle East and North Africa
8
Namibia
7
Senegal
6
Asia
6
Burkina Faso
5
Eastern Europe and Central Asia
5
Vietnam
5
Lesotho
4
Haiti
4
Central African Republic
4
Botswana
4
Indonesia
4
Thailand
3
China
3
Chile
3
Cameroon
3
Laos
3
USA
3
Paraguay
3
United Kingdom
3
Lebanon
3
Yemen
3
Angola
3
Turkey
2
Peru
2
Guinea-Bissau
2
Venezuela
2
Jordan
2
Spain
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Papua New Guinea
2
Sudan
2
Chad
2
Madagascar
2
Tajikistan
1
Mexico
1
El Salvador
1
Benin
1
Gambia
1
Iran
1
Albania
1
Kyrgyzstan
1
Niger
1
Malaysia
1
Morocco
1
Bulgaria
1
Italy
1
Western Pacific Region
1
Gabon
1
Japan
1
Denmark
1
France
1
Tunisia
1
Portugal
1
Southern Africa
1
Moldova
1
Honduras
1
Mali
1
Iraq
1
Somalia
1
Ecuador
1
Eswatini/ Swaziland
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
431
Clinical Guidelines
172
Women & Child Health
79
Public Health
74
Key Resources
41
Pharmacy & Technologies
21
Capacity Building
8
Toolboxes
COVID-19
320
HIV
112
TB
112
Ebola & Marburg
85
NTDs
74
AMR
61
Rapid Response
60
Pharmacy
35
Malaria
32
Mental Health
26
Health Financing Toolbox
24
Global Health Education
22
Planetary Health
21
Conflict
21
Refugee
19
Caregiver
16
NCDs
14
Cholera
13
Polio
13
Zika
12
Natural Hazards
5
Disability
5
Specific Hazards
4
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
Robust clinical research capacity in low- and middle-income countries is key to stemming the spread of epidemics, according to a new report from the International Vaccines Task Force (IVTF). The report lays out how to develop the political support, financing and coordination required to build this c...
Int J Vaccines Vaccin 2016, 2(1): 00018, January 29, 2016
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
Working Document Nov. 2020
The COVAX Supply and Logistics workstream lead by UNICEF, Gavi and WHO have released a working copy of the COVID-19 Vaccination, Country Readiness & Delivery: Supply and Logistics Guidance. Countries might find this Guide useful when developing and strengthening their sup...
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are...
Global procurement for COVID-19 vaccines
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i...
The focus of the current quarterly edition of Eurohealth (from the European Observatory on Health Systems and Policies) is Antimicrobial Resistance (AMR) and contains the following articles:
• Strengthening implementation of AMR national action plans
• Fostering clinical developmen...
This training module is designed to equip health workers (HWs) with
knowledge, skills, confidence and resources to help them in their role to recommend the Human Papillomavirus
(HPV) vaccine.
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
The guide explains how vaccines work and answers your common questions as well as providing up-to-date information on the current approved COVID-19 vaccinations in the UK.
This guide was written in January 2021 and updated in March 2021 and is accurate at the time of publishing. Information will b...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
